Works matching IS 19414390 AND DT 2008 AND VI 1 AND IP 1
Results: 31
A comparison of reimbursement for outpatient intraperitoneal chemotherapy versus intravenous therapy for ovarian cancer.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Making of a phase III study in recurrent ovarian cancer: the Odyssey of GOG 213.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Intraperitoneal chemotherapy: practicality versus theory.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Intraperitoneal chemotherapy for stage III ovarian cancer using the gynecologic oncology group protocol 172 intraperitoneal regimen: effect of supportive care using aprepitant and pegfilgrastim on treatment completion rate.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Investigating chemotherapy-induced nausea and vomiting.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Results of an open-label study to evaluate the efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with carboplatin-containing chemotherapy in patients with ovarian cancer, primary peritoneal, or fallopian tube carcinoma (stage I-IV) or papillary serous cancer of the uterus.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
HER2 overexpression/amplification and trastuzumab treatment in advanced ovarian cancer: a GINECO phase II study.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Erythropoiesis-stimulating agents and the practice of gynecologic oncology.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Maintenance therapy in epithelial ovarian cancer: rationale and results.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Clinical indications for human papillomavirus vaccination.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Debate: patients with recurrent ovarian cancer who experienced a clinical complete remission with initial platinum-based chemotherapy and had a treatment-free interval of at least six months before recurrence should receive platinum-based chemotherapy after any indicated surgery.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Making of a Phase III Study in Recurrent Ovarian Cancer: The Odyssey of GOG 213.
- Published in:
- Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 78, doi. 10.3816/COC.2008.n.009
- By:
- Publication type:
- Article
HER2 Overexpression/Amplification and Trastuzumab Treatment in Advanced Ovarian Cancer: A GINECO Phase II Study.
- Published in:
- Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 54, doi. 10.3816/COC.2008.n.005
- By:
- Publication type:
- Article
Intraperitoneal Chemotherapy: The Standard or an Option?
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Highlights from: The Annual Meeting of the Society of Gynecologic Oncologists; March 9-12, 2008; Tampa, FL.
- Published in:
- Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 10, doi. 10.1016/S1941-4390(11)70036-8
- By:
- Publication type:
- Article
Investigating Chemotherapy-Induced Nausea and Vomiting.
- Published in:
- 2008
- By:
- Publication type:
- Opinion
Debate: paclitaxel/doxorubicin/cisplatin is the best therapy for endometrial carcinoma.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Debate: patients with any stage I ovarian cancer should undergo complete surgical resection followed by six cycles of adjuvant carboplatin/paclitaxel.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Highlights from: the annual meeting of the Society of Gynecologic Oncologists: March 9-12, 2008; Tampa, FL.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Intraperitoneal chemotherapy: the standard or an option?
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Debate: Paclitaxel/Doxorubicin/Cisplatin Is the Best Therapy for Endometrial Carcinoma.
- Published in:
- Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 30
- By:
- Publication type:
- Article
Debate: Patients with Recurrent Ovarian Cancer Who Experienced a Clinical Complete Remission with Initial Platinum-Based Chemotherapy and Had a Treatment-Free Interval of at Least Six Months Before Recurrence Should Receive Platinum-Based Chemotherapy After Any Indicated Surgery.
- Published in:
- Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 22
- By:
- Publication type:
- Article
Debate: Patients with Any Stage I Ovarian Cancer Should Undergo Complete Surgical Resection Followed by Six Cycles of Adjuvant Carboplatin/Paclitaxel.
- Published in:
- Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 16
- By:
- Publication type:
- Article
Clinical Indications for Human Papillomavirus Vaccination.
- Published in:
- Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 36, doi. 10.3816/COC.2008.n.002
- By:
- Publication type:
- Article
Erythropoiesis-Stimulating Agents and the Practice of Gynecologic Oncology.
- Published in:
- Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 44, doi. 10.3816/COC.2008.n.004
- By:
- Publication type:
- Article
Intraperitoneal Chemotherapy for Stage III Ovarian Cancer Using the Gynecologic Oncology Group Protocol 172 Intraperitoneal Regimen: Effect of Supportive Care Using Aprepitant and Pegfilgrastim on Treatment Completion Rate.
- Published in:
- Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 68, doi. 10.3816/COC.2008.n.007
- By:
- Publication type:
- Article
A Comparison of Reimbursement for Outpatient Intraperitoneal Chemotherapy Versus Intravenous Therapy for Ovarian Cancer.
- Published in:
- Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 75, doi. 10.3816/COC.2008.n.008
- By:
- Publication type:
- Article
Maintenance Therapy in Epithelial Ovarian Cancer: Rationale and Results.
- Published in:
- Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 40, doi. 10.3816/COC.2008.n.003
- By:
- Publication type:
- Article
Results of an Open-Label Study to Evaluate the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Carboplatin-Containing Chemotherapy in Patients with Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Carcinoma (Stage I-IV) or Papillary Serous Cancer of the Uterus
- Published in:
- Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 60, doi. 10.3816/COC.2008.n.006
- By:
- Publication type:
- Article
Intraperitoneal Chemotherapy: Practicality Versus Theory.
- Published in:
- 2008
- By:
- Publication type:
- Opinion
Clinical Ovarian Cancer.
- Published in:
- 2008
- By:
- Publication type:
- Table of Contents